Collaborations and rising R&D investments by the prominent biotechnology and medical device companies are leading to the introduction of advanced orthobiologics which is expected to widen the base for growth of the orthobiologics. For instance, Bone Biologics Corp., is in development stages of its orthobiological product bone growth stimulator Nell-1, in collaboration (2015) with the University of California. This subsequent increase in R&D efforts led to development of a series of pipeline products that is projected to provide the vertical with profitable growth opportunities in the future.
The Orthobiologics Market is segmented on the basis of Product, Applications and region.
Major Types of Orthobiologics Market covered are:
- Introduction & Definition
- Demineralized Bone Matrix (DBM)
- Bone Morphogenetic Protein
- Viscosupplementation
- Allograft
- Stem Cell Therapy
- Others
Major Applications of Orthobiologics Market covered are:
- Introduction
- Spinal Fusion
- Trauma
- Soft-Tissue Injuries
- Reconstructive Surgery
- Other Applications
Osteoarthritis is one of the most disabling diseases majorly in developed countries. Substantial advances in treatment and surgical methods have provided effective options to decrease the disability and pain associated with some of the musculoskeletal conditions. Hip and knee joint replacement surgery is considered as the most effective intervention for severe form of osteoarthritis and fractures, reducing disability and pain, also restoring some patients to normal function. According to the data published by the OECD Health Statistics, in 2017, hip replacement rate is increased by 30% between 2000 and 2015 while the rate of knee replacement doubled.
No comments:
Post a Comment